These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10475192)

  • 21. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production.
    Tomer Y; Greenberg DA; Barbesino G; Concepcion E; Davies TF
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1687-93. PubMed ID: 11297604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex association analysis of graves disease using a set of polymorphic markers.
    Chistyakov DA; Savost'anov KV; Turakulov RI; Petunina NA; Trukhina LV; Kudinova AV; Balabolkin MI; Nosikov VV
    Mol Genet Metab; 2000 Jul; 70(3):214-8. PubMed ID: 10924276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese.
    Yanagawa T; Taniyama M; Enomoto S; Gomi K; Maruyama H; Ban Y; Saruta T
    Thyroid; 1997 Dec; 7(6):843-6. PubMed ID: 9459626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease.
    Donner H; Braun J; Seidl C; Rau H; Finke R; Ventz M; Walfish PG; Usadel KH; Badenhoop K
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4130-2. PubMed ID: 9398726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CTLA-4 gene polymorphism and its association with Graves' disease in the Lebanese population.
    Nakkash-Chmaisse H; Makki RF; Abdelhamid E; Fakhoury H; Salti NN; Salti I
    Eur J Immunogenet; 2004 Jun; 31(3):141-3. PubMed ID: 15182328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.
    Kouki T; Sawai Y; Gardine CA; Fisfalen ME; Alegre ML; DeGroot LJ
    J Immunol; 2000 Dec; 165(11):6606-11. PubMed ID: 11086105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic determinants of Graves disease.
    Chistyakov DA; Savost'anov KV; Turakulov RI; Nosikov VV
    Mol Genet Metab; 2000; 71(1-2):66-9. PubMed ID: 11001797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population.
    Imrie H; Vaidya B; Perros P; Kelly WF; Toft AD; Young ET; Kendall-Taylor P; Pearce SH
    J Clin Endocrinol Metab; 2001 Feb; 86(2):626-30. PubMed ID: 11158020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic markers in diagnosis and prediction of relapse in Graves' disease.
    Badenhoop K; Donner H; Braun J; Siegmund T; Rau H; Usadel KH
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():98-100. PubMed ID: 8981012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CTLA-4 (CD152) gene polymorphism at position 49 in exon 1 in Graves' disease in a Polish population of the Lower Silesian region.
    Frydecka I; Daroszewski J; Suwalska K; Zołedziowska M; Tutak A; Słowik M; Potoczek S; Dobosz T
    Arch Immunol Ther Exp (Warsz); 2004; 52(5):369-74. PubMed ID: 15507878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease.
    Vaidya B; Imrie H; Geatch DR; Perros P; Ball SG; Baylis PH; Carr D; Hurel SJ; James RA; Kelly WF; Kemp EH; Young ET; Weetman AP; Kendall-Taylor P; Pearce SH
    J Clin Endocrinol Metab; 2000 Feb; 85(2):688-91. PubMed ID: 10690877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of polymorphism at position 49 in exon 1 of the cytotoxic T-lymphocyte-associated factor 4 gene with Graves' disease refractory to medical treatment, but not with amiodarone-associated thyroid dysfunction.
    Kimura H; Kato Y; Shimizu S; Takano K; Sato K
    Thyroid; 2009 Sep; 19(9):975-81. PubMed ID: 19731979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genetics of Graves' disease.
    Gough SC
    Endocrinol Metab Clin North Am; 2000 Jun; 29(2):255-66. PubMed ID: 10874528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms in sarcoidosis patients.
    Hattori N; Niimi T; Sato S; Achiwa H; Maeda H; Oguri T; Bessho Y; Ito H; Shimizu S; Ueda R
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Mar; 22(1):27-32. PubMed ID: 15881277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.
    Skórka A; Bednarczuk T; Bar-Andziak E; Nauman J; Ploski R
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):679-82. PubMed ID: 15943829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population.
    Awata T; Kurihara S; Iitaka M; Takei S; Inoue I; Ishii C; Negishi K; Izumida T; Yoshida Y; Hagura R; Kuzuya N; Kanazawa Y; Katayama S
    Diabetes; 1998 Jan; 47(1):128-9. PubMed ID: 9421386
    [No Abstract]   [Full Text] [Related]  

  • 37. Cytotoxic T lymphocyte-associated antigen-4 gene polymorphisms confer susceptibility to atopic asthma in Korean children.
    Sohn MH; Kim SH; Song TW; Kim KW; Kim ES; Park HS; Kim KE
    Pediatr Pulmonol; 2007 Jun; 42(6):542-7. PubMed ID: 17469155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies.
    Heward JM; Allahabadia A; Carr-Smith J; Daykin J; Cockram CS; Gordon C; Barnett AH; Franklyn JA; Gough SC
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):331-4. PubMed ID: 9861324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population.
    Yanagawa T; Hidaka Y; Guimaraes V; Soliman M; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Jan; 80(1):41-5. PubMed ID: 7829637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of HLA-DRB1 alleles with CTLA-4 in the predisposition to Graves' disease: the impact of DRB1*07.
    Kula D; Bednarczuk T; Jurecka-Lubieniecka B; Polanska J; Hasse-Lazar K; Jarzab M; Steinhof-Radwanska K; Hejduk B; Zebracka J; Kurylowicz A; Bar-Andziak E; Stechly T; Pawlaczek A; Gubala E; Krawczyk A; Szpak-Ulczok S; Nauman J; Jarzab B
    Thyroid; 2006 May; 16(5):447-53. PubMed ID: 16756466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.